Expression of α-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor.
The membrane traffic system has been recognized to be involved in carcinogenesis and tumor progression in several types of tumors. α-taxilin is a newly identified membrane traffic-related molecule, and its up-regulation has been reported in embryonic and malignant tissues of neural origin. In the present study, we analyzed the expression of α-taxilin in relation to clinicopathological features of hepatocellular carcinomas (HCC) and proliferative activity of the tumor determined by proliferating cell nuclear antigen labeling index (PCNA-LI). Twenty-nine surgically resected nodules of HCC (8 well-, 11 moderately-, and 10 poorly-differentiated) were studied. Fifteen cases showed 'strong staining', while 14 cases showed 'weak staining' for α-taxilin. A significantly higher expression of α-taxilin was observed in less-differentiated (p=0.005), and more invasive (p=0.016) HCCs. The 'strong staining' group showed significantly higher PCNA-LI than the 'weak staining' group (the medians of PCNA-LI were 59.4% vs. 14.4%, p<0.0001). We also evaluated the expression of α-taxilin in hepatoma cell lines (PLC/PRF/5, Hep G2 and HuH-6) in association with cell proliferation. The expression levels of α-taxilin protein were correlated with their growth rates. In conclusion, the expression of the α-taxilin protein was related with an increased proliferative activity and a less-differentiated histological grade of HCC. α-taxilin may be involved in cell proliferation of HCC, and its expression can be a marker of malignant potential of HCC.
Department of Gastroenterology, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Natsuko
N
Ohtomo
Tomoaki
T
Tomiya
Yasushi
Y
Tanoue
Yukiko
Y
Inoue
Takako
T
Nishikawa
Hitoshi
H
Ikeda
Yasuji
Y
Seyama
Norihiro
N
Kokudo
Junji
J
Shibahara
Masashi
M
Fukayama
Kazuhiko
K
Koike
Hiromichi
H
Shirataki
Kenji
K
Fujiwara
D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism / Q000502:physiology; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D005260:Female; D056945:Hep G2 Cells; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D033921:Vesicular Transport Proteins / Q000378:metabolism* / Q000502:physiology
D014408:Biomarkers, Tumor; C488100:TXLNA protein, human; D033921:Vesicular Transport Proteins